![Sunitinib Malate Size:Solid 2 mg 5-dimethyloxan-2-yl]-3'-methyl-[2](https://cdn.shopify.com/s/files/1/0389/1897/9723/files/1685434790803.png?v=1685434812)
Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
5-dimethyloxan-2-yl]-3'-methyl-[2
also known as PSI-6206 and RO-2433
HeLa and HT-29 cells) treatment significantly increases the cytotoxicity of DNA damage
Dictamnine
CAS Number: 303727-31-3
Sunitinib Malate Size:Solid 2 mg 5-dimethyloxan-2-yl]-3'-methyl-[2Sunitinib, also known as SU11248, is the orally bioavailable malate salt of an indolinone based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet derived
US$ 160.00
US$ 130.00
US$ 198.00
US$ 369.00